at Zacks.com (Wed, 8:46AM)
A recent FDA report cites serious flaws in St. Jude Medical's oversight of design changes made to its Durata line of devices. Earlier this year, STJ had released a heavily redacted version of the FDA's report, but the recent release of the same report by the FDA shows highlights a pattern of inadequate verification and flawed testing procedures that could renew concerns over the safety of the Durata device. Shares -0.3% AH.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Tue, 6:10PM)
at Zacks.com (Jan 15, 2015)
at Zacks.com (Jan 8, 2015)
at Nasdaq.com (Dec 29, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs